Scholars Central

Conference abstractPublished 2019

Implementing modern cell engineering and process development approaches for affordable and sustainable biosimilar manufacturing

Authors: Sanjeev Gupta

Ipca Laboratories Ltd., India

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

I will give a General Overview of Biosimilars/ Biologics and opportunities for the Biopharma players followed by implementation of modern tools described below for affordable biosimilar and Biologisc development: 1. Implementation of Gene editing tools CRISPR and TALENS for cell line engineering and production improvement 2. Modern approaches for high producer cell line and robust upstream process development 3. Use of cutting edge technologies to improve biosimilar development and manufacturing 4. Factors influences protein expression and critical quality attributes including glycosylation of monoclonal antibodies 5. mAb glycosylation and its overall Impact on biosimilarity and product performance 6. Case studies on titer and quality improvement at clone and process level for affordable biosimilar development

Subjects

Biology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Cell Biology: Research & Therapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalCell Biology: Research & Therapy
  • SubjectBiology
  • BylineArticles whose byline prints “Sanjeev Gupta”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels